| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.03B | +27.1% |
| Cost of Revenue | $597.7M | +17.4% |
| R&D Expense | $76.6M | +2.9% |
| SG&A Expense | $240.8M | +18.4% |
| Operating Income | $66.8M | +373.9% |
| Pre-tax Income | -$421.1M | -132.4% |
| Income Tax | $24.6M | +57.8% |
| Net Income | -$401.4M | -212.5% |
| EPS (Basic) | -$5.66 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $187.9M | +0.8% |
| Accounts Receivable | $112.2M | +41.1% |
| Current Assets | $351.5M | +15.8% |
| Total Assets | $1.29B | +6.8% |
| Current Liabilities | $195.5M | +160.9% |
| Long-term Debt | $321.3M | — |
| Total Liabilities | $775.3M | +65.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $66.5M | +594.6% |
| Capital Expenditures | $17.7M | -12.1% |
| Investing Cash Flow | -$498.6M | -20.8% |
| Financing Cash Flow | $436.7M | +51.1% |
| Free Cash Flow | $48.8M | +559.7% |
| -164.5% |
| EPS (Diluted) | -$5.66 | -164.5% |
| Stockholders' Equity |
| $326.5M |
| -41.7% |